» Articles » PMID: 12532371

Thermal Stability of Vaccines

Overview
Journal J Pharm Sci
Publisher Elsevier
Specialties Pharmacology
Pharmacy
Date 2003 Jan 18
PMID 12532371
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Worldwide vaccination programs against infectious diseases and toxins are estimated to save approximately 3 million lives yearly. Tragically, however, another 3 million individuals (primarily children) die of vaccine-preventable diseases. A significant portion of this problem results from the thermal instability of many of the currently used vaccines. This review argues that modern methods of physical and chemical analysis permit for the first time characterization of the degradative pathways of thermally labile vaccines. A rigorous description of these pathways permit a more rational and systematic approach to the stabilization of vaccines. A direct result of the replacement of currently employed, primarily empirical, approaches to vaccine stabilization with a more molecular-based methodology should be the development of more universally available vaccinations against life-threatening diseases. This has the potential to have a dramatic impact on world health.

Citing Articles

Respiratory delivered vaccines: Current status and perspectives in rational formulation design.

Wu L, Xu W, Jiang H, Yang M, Cun D Acta Pharm Sin B. 2025; 14(12):5132-5160.

PMID: 39807330 PMC: 11725141. DOI: 10.1016/j.apsb.2024.08.026.


Development of Long-Term Stability of Enveloped rVSV Viral Vector Expressing SARS-CoV-2 Antigen Using a DOE-Guided Approach.

Khan M, Wagner C, Kamen A Vaccines (Basel). 2024; 12(11).

PMID: 39591143 PMC: 11598241. DOI: 10.3390/vaccines12111240.


Mechanistic insights into structure-based design of a Lyme disease subunit vaccine.

Brangulis K, Malfetano J, Marcinkiewicz A, Wang A, Chen Y, Lee J bioRxiv. 2024; .

PMID: 39554036 PMC: 11565809. DOI: 10.1101/2024.10.23.619738.


A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens.

Kramarska E, Toumi E, Squeglia F, Laverde D, Napolitano V, Frapy E NPJ Vaccines. 2024; 9(1):151.

PMID: 39155280 PMC: 11330964. DOI: 10.1038/s41541-024-00940-x.


Determination of Deamidation in Adjuvanted Vaccine Antigens through Isoaspartic Acid Quantification.

Hasija M, Ma J, Li B, Rahman N, Strahlendorf K, Ausar S Vaccines (Basel). 2024; 12(7).

PMID: 39066371 PMC: 11281650. DOI: 10.3390/vaccines12070733.